Halogenated mazindol analogs as potential inhibitors of the cocaine binding site at the dopamine transporter.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Medicinal Chemistry

• Publication date

  1996-12-06

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM960288WPMID 8960553
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Psychostimulant self-administration by beagle dogs in a progressive-ratio paradigm

  2004cited by this paper
• Synthesis and pharmacology of potential cocaine antagonists. 2. Structure-activity relationship studies of aromatic ring-substituted methylphenidate analogs.

  1996cited by this paper
• Mazindol for relapse prevention to cocaine abuse in methadone-maintained patients.

  1995cited by this paper
• Structure-activity relationship studies of N-sulfonyl analogs of cocaine: role of ionic interaction in cocaine binding.

  1994cited by this paper
• Intersecting epidemics--crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study Team.

  1994cited by this paper
• Differential relationships among dopamine transporter affinities and stimulant potencies of various uptake inhibitors.

  1994cited by this paper
• Synthesis of 2 beta-acyl-3 beta-aryl-8-azabicyclo[3.2.1]octanes and their binding affinities at dopamine and serotonin transport sites in rat striatum and frontal cortex.

  1994cited by this paper
• Release of dopamine via the human transporter.

  1994cited by this paper
• Effects of three monoamine uptake inhibitors on behavior maintained by cocaine or food presentation in rhesus monkeys.

  1993cited by this paper
• Effects of mazindol on behavior maintained or occasioned by cocaine.

  1993cited by this paper
• Differing Neurotoxic Potencies of Methamphetamine, Mazindol, and Cocaine in Mesencephalic Cultures

  1993cited by this paper
• Effects of cocaine alone and in combination with mazindol in human cocaine abusers.

  1993cited by this paper
• Molecular characterization of the dopamine transporter.

  1993cited by this paper
• Synthesis of carbon-11 labeled iodinated cocaine derivatives and their distribution in baboon brain measured using positron emission tomography.

  1992cited by this paper
• Appetite suppressants. A review.

  1992cited by this paper
• A novel class of calcium-entry blockers: the 1[[4-(aminoalkoxy)phenyl]sulfonyl]indolizines.

  1992cited by this paper
• Cocaine and dopamine differentially protect [3H]mazindol binding sites from alkylation by N-ethylmaleimide.

  1992cited by this paper
• Radiolabeling of dopamine uptake sites in mouse striatum: comparison of binding sites for cocaine, mazindol, and GBR 12935

  1992cited by this paper
• Cocaine receptor: biochemical characterization and structure-activity relationships of cocaine analogues at the dopamine transporter.

  1992cited by this paper
• Effect of cocaine use on the fetus.

  1992cited by this paper
• The dopamine hypothesis of the reinforcing properties of cocaine.

  1991cited by this paper
• Synthesis, ligand binding, QSAR, and CoMFA study of 3 beta-(p-substituted phenyl)tropane-2 beta-carboxylic acid methyl esters.

  1991cited by this paper
• Randomized, double‐blind trial of mazindol in Duchenne dystrophy

  1990cited by this paper
• High affinity dopamine reuptake inhibitors as potential cocaine antagonists: a strategy for drug development.

  1990cited by this paper
• Cocaine-mediated impairment of cardiac conduction in the dog: a potential mechanism for sudden death after cocaine.

  1990cited by this paper
• Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade.

  1990cited by this paper
• Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys.

  1989cited by this paper
• Nocturnal rhythm of growth hormone in Duchenne patients: effect of different doses of mazindol and/or cyproheptadine.

  1989cited by this paper
• Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior.

  1989cited by this paper
• Reversible cardiomyopathy associated with cocaine intoxication.

  1989cited by this paper
• Treatment of cocaine abuse with mazindol.

  1989cited by this paper
• Anorectic activities of serotonin uptake inhibitors: correlation with their potencies at inhibiting serotonin uptake in vivo and 3H-mazindol binding in vitro.

  1988cited by this paper
• Partial complex status epilepticus associated with cocaine abuse.

  1988cited by this paper
• Neurologic aspects of cocaine abuse.

  1988cited by this paper
• The effect of mazindol on growth hormone secretion in boys with Duchenne muscular dystrophy.

  1988cited by this paper
• Cocaine inhibits muscarinic cholinergic receptors in heart and brain.

  1988cited by this paper
• Anorectics: effects on food intake and self-administration in rhesus monkeys.

  1987cited by this paper
• Cocaine receptors on dopamine transporters are related to self-administration of cocaine.

  1987cited by this paper
• Reinforcing and subjective effects of several anorectics in normal human volunteers.

  1987cited by this paper
• Medical complications of cocaine abuse.

  1986cited by this paper
• The discriminative stimulus and subjective effects of phenylpropanolamine, mazindol and d-amphetamine in humans.

  1986cited by this paper
• Botulism and botulism-like illness in chronic drug abusers.

  1985cited by this paper
• [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.

  1984cited by this paper
• Fungal cerebritis from intravenous drug abuse.

  1984cited by this paper
• Pharmacological studies with several analogs of mazindol: correlation between effects on dopamine uptake and various in vivo responses.

  1981cited by this paper
• Unexpected differences between mazindol and its homologs on biochemical and behavioral responses.

  1981cited by this paper
• Mazindol self-administration in the rhesus monkey.

  1976cited by this paper
• Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain.

  1976cited by this paper
• 5-aryl-2,3-dihydro-5H-imidazo[2,1-a]isoindol-5-ols. A novel class of anorectic agents.

  1975cited by this paper
• Neuroleptic agents of the benzocycloheptapyridoisoquinoline series. 1. Syntheses and stereochemical and structural requirements for activity of butaclamol and related compounds.

  1975cited by this paper
• Pharmacological analysis of a new anorexic substance: 5-hydroxy-5(4'-chlorophenyl)-2, 3-dihydro-5H-imidazo-(2, 1-a) isoindole (Mazindol).

  1975cited by this paper
• DOPAMINE IN THE MESOLIMBIC SYSTEM OF THE RAT BRAIN: ENDOGENOUS LEVELS AND THE EFFECTS OF DRUGS ON THE UPTAKE MECHANISM AND STIMULATION OF ADENYLATE CYCLASE ACTIVITY

  1974cited by this paper
• Uptake of (3H)-catecholamines by homogenates of rat corpus striatum and cerebral cortex: effects of amphetamine analogues.

  1973cited by this paper
• Subjective effects of two anorexigenic agents fenfluramine and AN 448 in amphetamine-dependent subjects.

  1972cited by this paper
• Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue.

  1969cited by this paper
• Double-blind comparison of placebo and 42-548, a new appetite suppressant, in obese volunteers.

  1969cited by this paper
• Antiparkinsonian Drugs: Inhibition of Dopamine Uptake in the Corpus Striatum as a Possible Mechanism of Action

  1969cited by this paper
• 5-hydroxytryptamine uptake by rat brain in vitro.

  1967cited by this paper
• Amidines; preparation of 2-substituted 4 : 5-dihydro-glyoxalines and ring homologues from cyanides and alkylenediamines.

  1947cited by this paper

• Serotonergic Drugs for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Review of Past Development, Pitfalls and Failures, and a Look to the Future.

  2024cites this paper
• 1,3‐Diazepine: A privileged scaffold in medicinal chemistry

  2021cites this paper
• “Cell-addictive” dual-target traceable nanodrug for Parkinson's disease treatment via flotillins pathway

  2018cites this paper
• Cyclodehydration of N-(aminoalkyl)benzamides under mild conditions with a Hendrickson reagent analogue.

  2013cites this paper
• Rapid and Efficient Synthesis of Imidazolines and Bisimidazolines Under Microwave and Ultrasonic Irradiation

  2007cites this paper
• Agonistic and antagonistic bivalent ligands for serotonin and dopamine receptors including their transporters.

  2007cites this paper
• Rapid and efficient synthesis of 2-imidazolines and bis-imidazolines under ultrasonic irradiation

  2006cites this paper
• Effects of monoamine reuptake inhibitors on wet-dog shakes mediated by 5-HT2A receptors in ACTH-treated rats.

  2005cites this paper
• Reactions of some ortho and para halogenated aromatic nitriles with ethylenediamine: selective synthesis of imidazolines☆

  2004cites this paper
• Dopamine transporter as target for drug development of cocaine dependence medications.

  2003cites this paper
• Assessment of mazindane, a pro-drug form of mazindol, in assays used to define cocaine treatment agents.

  2003cites this paper
• Molecular approaches to treatments for cocaine abuse

  2003cites this paper
• Benzo- and cyclohexanomazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.

  2002cites this paper
• Identification of a novel partial inhibitor of dopamine transporter among 4-substituted 2-phenylquinazolines.

  2002cites this paper
• Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.

  2002cites this paper
• Three-dimensional quantitative structure-activity relationships of mazindol analogues at the dopamine transporter.

  2002cites this paper
• Discovery of substituted 3,4-diphenyl-thiazoles as a novel class of monoamine transporter inhibitors through 3-D pharmacophore search using a new pharmacophore model derived from mazindol.

  2002cites this paper
• Pharmacological and behavioral analysis of the effects of some bivalent ligand-based monoamine reuptake inhibitors.

  2001cites this paper
• Molecular modeling, structure--activity relationships and functional antagonism studies of 4-hydroxy-1-methyl-4-(4-methylphenyl)-3-piperidyl 4-methylphenyl ketones as a novel class of dopamine transporter inhibitors.

  2001cites this paper
• Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.

  2000cites this paper
• The maximal affinity of ligands.

  1999cites this paper
• Conformational Analysis and a Crystal Structure of Bupropion, an Antidepressant with Dopamine Reuptake Blocking Activity

  1998cites this paper
• Cocaine sensitivity in Borna disease virus-infected rats.

  1998cites this paper
• High Affinity Recognition of Serotonin Transporter Antagonists Defined by Species-scanning Mutagenesis

  1998cites this paper
• Dopamine-Transporter Uptake Blockers

  1997cites this paper
• Synthesis of 1‐halophenyl 4‐(2‐imidazolyl)‐1‐butanones and 5‐(2‐imidazolyl)‐1‐pentanones and their ketalization with glycerol

  1997cites this paper
• Dopamine transporter uptake blockers: Structure-activity relationships

  1995cites this paper